Tackling antimicrobial resistance- a story of a community playing its part.
This first volume of comic strips is titled "tackling antimicrobial resistance: a story of a community playing its part". It basically contains messages tailored for individuals at the grassroot.
Take Action on Antimicrobial Resistance. For Farmers
Biennial Report. SUBMITTED TO THE UNITED NATIONS GENERAL ASSEMBLY SPECIAL SESSION ON HIV AND AIDS
Reporting period: January 2012 – December 2013
Take Action on Antimicrobial Resistance. For students in high school.
This AMR booklet is designed to inform high school students on AMR and how they can prevent it on a personal level. It is a brief document that has the potential to capture their interest as they learn from it.
Like the first volume, this one contains messages for the community but they are presented in a different version.
Fact sheet on Tuberculosis in Rwanda
Living Conditions Among Persons with Disability Survey Report
Training manual that outlines the training of smallholder farmers to improve biosecurity and practices in their farms to prevent infectious diseases and thus the need for use of veterinary drugs. Describes training sessions and includes exercises and handouts.
This film is the Luganda version of 'Food for Life: Breastfeeding' - this was dubbed locally in Uganda, thanks to the Royal College of Paediatrics and Child Health.
The international community sits at the tipping pointof a post-‐antibiotic era, where common bacterial infections are no longer treatable with the antibiotic armamentarium that exists. In South Africa, t...he identification of the first case of pan-‐resistant Klebsiella pneumoniae(Brink et al, J Clin Microbiol. 2013;51(1):369-‐72) marks a watershed moment and highlights ourtip of the antibiotic resistance ‘iceberg’ in this country. Multi-‐drug resistant (MDR)-‐bacterial infections, predominantly in Gram-‐negative bacteria such as Klebsiella pneumoniae, Escherichia coli, Pseudomonas aeruginosaand Acinetobacter baumanniiare now commonplace in South African hospitals. Whilst a number of expensive new antibiotics for Gram-‐positive bacterial infections have been manufactured recently (some of which are licenced for usein South Africa), no new antibiotics active against Gram-‐negative infections are expected in the next 10-‐15years. Hence what we have now, needs conserving
more